Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma

Clinical trial NCT03505944 · UNKNOWN

Trial details

NCT number: NCT03505944
Sponsor: Nordic Lymphoma Group
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed Non Hodgkin Lymphoma

Start date: 2018-07-01
Primary completion: 2022-12-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.